{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:49:03Z","timestamp":1772754543912,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13104-017-2402-6","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T01:15:03Z","timestamp":1485998103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka"],"prefix":"10.1186","volume":"10","author":[{"given":"Nalaka","family":"Herath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelakanthi","family":"Ratnatunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosala","family":"Weerakoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Wazil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishantha","family":"Nanayakkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"2402_CR1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.V102413","volume":"10","author":"JS Cameron","year":"1999","unstructured":"Cameron JS. Lupus nephritis. J Am Soc Nephrol. 1999;10:413\u201324.","journal-title":"J Am Soc Nephrol"},{"key":"2402_CR2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.30293","volume":"63","author":"KH Costenbader","year":"2011","unstructured":"Costenbader KH, Desai A, Alarc\u00f3n GS, Hiraki LT, Shaykevich T, Brookhart MA, et al. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011;63:1681\u20138.","journal-title":"Arthritis Rheum"},{"key":"2402_CR3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3899\/jrheum.091199","volume":"37","author":"MM Ward","year":"2010","unstructured":"Ward MM. Access to care and the incidence of endstage renal disease due to systemic lupus erythematosus. J Rheumatol. 2010;37:1158\u201363.","journal-title":"J Rheumatol"},{"key":"2402_CR4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/acr.20116","volume":"62","author":"M Faurschou","year":"2010","unstructured":"Faurschou M, Dreyer L, Kamper A-L, Starklint H, Jacobsen S. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken). 2010;62:873\u201380.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"2402_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","volume":"69","author":"FA Houssiau","year":"2010","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis. 2010;69:61\u20134.","journal-title":"Ann Rheum Dis"},{"key":"2402_CR6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4038\/cmj.v45i4.6589","volume":"45","author":"P Galapatthy","year":"2000","unstructured":"Galapatthy P, Wazeel AN, Nanayakkara S, Sheriff R. Clinical features of systemic lupus erythematosus in Sri Lankan patients: results from a lupus clinic. Ceylon Med J. 2000;45:162\u20135.","journal-title":"Ceylon Med J"},{"key":"2402_CR7","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, de Garrido Ed ER, Danieli MG, et al. Immunosuppressive therapy in lupus nephritis: the Euro-lupus nephritis trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002;46:2121\u201331.","journal-title":"Arthritis Rheum"},{"key":"2402_CR8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/acr.21597","volume":"64","author":"V Dhir","year":"2012","unstructured":"Dhir V, Aggarwal A, Lawrence A, Agarwal V, Misra R. Long-term outcome of lupus nephritis in Asian Indians. Arthritis Care Res (Hoboken). 2012;64:713\u201320.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"2402_CR9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1681\/ASN.2004080686","volume":"16","author":"T-M Chan","year":"2005","unstructured":"Chan T-M, Tse K-C, Tang CS-O, Mok M-Y, Li F-K, Hong Kong Nephrology Study Group. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol. 2005;16:1076\u201384.","journal-title":"J Am Soc Nephrol"},{"key":"2402_CR10","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/ndt\/gfm245","volume":"22","author":"G Moroni","year":"2007","unstructured":"Moroni G, Quaglini S, Gallelli B, Banfi G, Messa P, Ponticelli C. The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol Dial Transpl. 2007;22:2531\u20139.","journal-title":"Nephrol Dial Transpl."},{"key":"2402_CR11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/art.10138","volume":"46","author":"CC Mok","year":"2002","unstructured":"Mok CC, Ho CTK, Chan KW, Lau CS, Wong RWS. Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum. 2002;46:1003\u201313.","journal-title":"Arthritis Rheum"},{"key":"2402_CR12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/qjmed\/92.4.211","volume":"92","author":"L Bono","year":"1999","unstructured":"Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment. QJM. 1999;92:211\u20138.","journal-title":"QJM"},{"key":"2402_CR13","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1002\/art.20666","volume":"50","author":"FA Houssiau","year":"2004","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-lupus nephritis trial. Arthritis Rheum. 2004;50:3934\u201340.","journal-title":"Arthritis Rheum"},{"key":"2402_CR14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ki.1994.70","volume":"45","author":"HA Austin","year":"1994","unstructured":"Austin HA, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 1994;45:544\u201350.","journal-title":"Kidney Int"},{"key":"2402_CR15","first-page":"1620","volume":"10","author":"HA Austin","year":"1995","unstructured":"Austin HA, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transpl. 1995;10:1620\u20138.","journal-title":"Nephrol Dial Transpl."},{"key":"2402_CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.7326\/0003-4819-116-2-114","volume":"116","author":"AS Levey","year":"1992","unstructured":"Levey AS, Lan SP, Corwin HL, Kasinath BS, Lachin J, Neilson EG, et al. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med. 1992;116:114\u201323.","journal-title":"Ann Intern Med"},{"key":"2402_CR17","first-page":"2052","volume":"21","author":"L Fraenkel","year":"1994","unstructured":"Fraenkel L, MacKenzie T, Joseph L, Kashgarian M, Hayslett JP, Esdaile JM. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis. J Rheumatol. 1994;21:2052\u20137.","journal-title":"J Rheumatol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-017-2402-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T06:16:20Z","timestamp":1658556980000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-017-2402-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2402"],"URL":"https:\/\/doi.org\/10.1186\/s13104-017-2402-6","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]},"article-number":"80"}}